RICCI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 142
AS - Asia 122
SA - Sud America 31
EU - Europa 27
AF - Africa 3
OC - Oceania 2
Totale 327
Nazione #
US - Stati Uniti d'America 139
SG - Singapore 73
CN - Cina 32
BR - Brasile 29
IT - Italia 8
DE - Germania 4
FI - Finlandia 4
IE - Irlanda 4
KR - Corea 4
GB - Regno Unito 3
BD - Bangladesh 2
HK - Hong Kong 2
IN - India 2
PL - Polonia 2
TR - Turchia 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
CA - Canada 1
DM - Dominica 1
ES - Italia 1
IQ - Iraq 1
MA - Marocco 1
MX - Messico 1
NP - Nepal 1
NR - Nauru 1
PK - Pakistan 1
TN - Tunisia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 327
Città #
Singapore 63
Santa Clara 59
Los Angeles 20
Beijing 14
Hefei 12
Ashburn 7
Chicago 6
Civitanova Marche 4
Dublin 4
Seoul 4
Turku 4
Boardman 3
Atlanta 2
Bastiglia 2
Curitiba 2
Dhaka 2
Hong Kong 2
Munich 2
Porto Alegre 2
São Paulo 2
Vitória 2
Warsaw 2
Bady Bassitt 1
Boston 1
Brooklyn 1
Cambridge 1
Caracas 1
Carapicuíba 1
Caratinga 1
Casablanca 1
Catania 1
Chennai 1
Citrus Heights 1
Cleveland 1
Covington 1
Dallas 1
Erbil 1
Flat Rock 1
Fontana 1
Gonzales 1
Gravataí 1
Guarulhos 1
Hanoi 1
Kahramanmaraş 1
Karachi 1
Karlsruhe 1
Konya 1
Laguna 1
Lawrence 1
London 1
Magnolia 1
Manaus 1
Montreal 1
Moreilândia 1
Naperville 1
New York 1
Newham 1
Nipomo 1
Niterói 1
Nova Serrana 1
Nuremberg 1
Palmdale 1
Parnamirim 1
Petrópolis 1
Piraí do Sul 1
Praia Grande 1
Ribeirão Preto 1
Roseau 1
Salvador 1
San Francisco 1
San Jose 1
Santa Cruz 1
Sarandi 1
Slough 1
Suzano 1
Sydney 1
São Francisco do Sul 1
São Vicente 1
The Bronx 1
Thành Phố Bà Rịa 1
Thāne 1
Tunis 1
Ubá 1
Vienna 1
Virginia Beach 1
Wilkesboro 1
Yaren District 1
Zapopan 1
Totale 286
Nome #
Discovering cosmic rays with OCRA: outreach activities for students and teachers 54
The online laboratories for OCRA - Outreach Cosmic Ray Activities INFN project 38
Further delineation and long-term evolution of electroclinical phenotype in Mowat Wilson Syndrome. A longitudinal study in 40 individuals 35
Weight gain: A possible side effect of all antiretrovirals 22
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 21
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 19
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 19
Factors associated with weight gain in people treated with dolutegravir 18
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 13
The effect of switching from tenofovir disoproxil fumarate (Tdf) to tenofovir alafenamide (taf) on liver enzymes, glucose, and lipid profile 10
Effectiveness of first-generation HCV protease inhibitors: Does HIV coinfection still play a role? 10
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 10
Low frequency of skin reactions in a cohort of patients on raltegravir 10
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: The SALIR-E Study 9
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 9
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 9
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 9
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 9
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 8
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project) 8
Decreasing cardiovascular risk in HIV infection between 2005 and 2011 8
Totale 348
Categoria #
all - tutte 2.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 1 0 1
2022/20235 1 0 0 0 0 1 0 1 2 0 0 0
2023/202412 0 0 1 1 0 0 0 0 0 2 6 2
2024/2025235 1 9 5 6 44 28 6 5 27 31 26 47
2025/202694 58 36 0 0 0 0 0 0 0 0 0 0
Totale 348